Table 2 Comparison between survival-related genes and cancer driver genes

 KIRC

7770

46.9%

(340/725) **

0%

(0/3)

50%

(6/12)

 LGG

6691

32.5%

(570/1752)

82.2%

(37/45) ***

–

 ACC

5243

19.7%

(74/375)

32.3%

(40/124)

–

 UVM

3765

25%

(9/36)

62%

(75/121) ***

–

 LIHC

2359

9.5%

(106/1113)

9.6%

(8/83)

6.6%

(12/181)

 PRAD

1538

5.1%

(58/1141)

23.5%

(4/17)

4.4%

(3/68)

 MESO

586

2.5%

(1/40)

0%

(0/1)

–

 PAAD

443

1.6%

(16/971)

0%

(0/2)

16%

(4/25)**

 KIRP

238

1.9%

(12/631)

1.1%

(1/87)

2.2%

(5/224)

 BLCA

39

0.2%

(6/2404)

0%

(0/104)

0%

(0/443)

 CESC

35

0.2%

(4/1815)

0%

(0/52)

–

 LAML

29

0%

(0/413)

0%

(0/3)

–

 HNSC

18

0%

(0/1914)

1%

(1/103)

0%

(0/89)

 STAD

10

0.1%

(4/3695)

0%

(0/86)

–

 LUAD

8

0%

(1/2903)

0%

(0/37)

0%

(0/18)

 SKCM

1

0%

(0/4559)

0%

(0/18)

–

 KIRC

7091

38.3%

(278/725)

0%

(0/3)

50%

(6/12)

 ACC

6467

25.9%

(97/375)

43.5%

(54/124)

–

 UVM

5600

33.3%

(12/36)

84.3%

(102/121) ***

–

 LGG

5418

27.2%

(476/1752)

42.2%

(19/45) ***

–

 PAAD

4287

21.2%

(206/971)

0%

(0/2)

36%

(9/25)*

 LIHC

2384

10%

(111/1113)

8.4%

(7/83)

9.9%

(18/181)

 PRAD

2068

8.1%

(92/1141)

35.3%

(6/17) *

5.9%

(4/68)

 MESO

728

2.5%

(1/40)

0%

(0/1)

–

 KIRP

592

2.4%

(15/631)

2.3%

(2/87)

1.8%

(4/224)

 BLCA

442

2.7%

(64/2404)

1%

(1/104)

1.6%

(7/443)

 KICH

407

3.7%

(2/54)

–

–

 CESC

230

1.4%

(25/1815)

0%

(0/52)

–

 HNSC

204

0.9%

(17/1914)

1.9%

(2/103)

0%

(0/89)

 LAML

158

0.7%

(3/413)

0%

(0/3)

–

 LUAD

71

0.4%

(12/2903)

5.4%

(2/37) **

0%

(0/18)

 PCPG

64

2%

(1/49)

0%

(0/5)

–

 BRCA

24

0.1%

(2/2162)

0%

(0/220)

0%

(0/36)

 UCEC

5

0%

(0/6669)

0%

(0/76)

–

 STAD

3

0%

(1/3695)

0%

(0/86)

–

 SARC

2

0%

(0/543)

0%

(0/104)

–

 THCA

2

0%

(0/192)

0%

(0/3)

0%

(0/201)